Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire

被引:54
作者
Navines, R. [1 ,2 ]
Castellvi, P. [1 ,2 ]
Moreno-Espana, J. [1 ,2 ,3 ]
Gimenez, D. [4 ]
Udina, M. [1 ,2 ,3 ]
Canizares, S. [1 ,2 ]
Diez-Quevedo, C. [5 ]
Valdes, M. [1 ,2 ,3 ]
Sola, R. [4 ]
Martin-Santos, R. [1 ,2 ,3 ]
机构
[1] Univ Barcelona, Hosp Clin, Inst Neurosci, Dept Psychiat,IDIBAPS,CIBERSAM, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Inst Neurosci, Dept Psychol,IDIBAPS,CIBERSAM, E-08036 Barcelona, Spain
[3] Univ Barcelona, Dept Psychiat & Clin Psychobiol, E-08036 Barcelona, Spain
[4] Autonomous Univ Barcelona, Liver Unit, Barcelona, Spain
[5] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, Dept Psychiat, Barcelona, Spain
关键词
Chronic hepatitis C; Depression; Anxiety; PHQ; Screening instrument; Validation; QUALITY-OF-LIFE; DIAGNOSING MENTAL-DISORDERS; INTERFERON-ALPHA; HOSPITAL ANXIETY; SCREENING TOOL; PRIMARY-CARE; VIRUS; VALIDATION; SYMPTOMS; UTILITY;
D O I
10.1016/j.jad.2012.01.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depression and anxiety in patients with hepatitis C virus (HCV) infection influence their health-related quality of life and their adherence to antiviral treatment. Objective: To study the psychometric properties of the Patient Health Questionnaire (PHQ) as a screening instrument for depression and anxiety in HCV patients. Methods: Criterion validity, using the structured clinical interview for DSM-IV-Axis I (SCID-I) to diagnose depression and anxiety disorders as diagnostic standard, was evaluated for both summed and algorithm-based PHQ in 500 HCV patients. Correlations with quality of life (Short-Form-36 Health Survey; SF-36) and severity of illness (Hospital Anxiety and Depression Scale; HADS) were calculated to assess construct validity. Test-retest reliability and patients' reaction to the PHQ were assessed in 120 HCV patients. Results: Twenty-three percent of patients (N = 114) had a psychiatric disorder (any depressive disorder = 18.2%; major depressive disorder = 6.4%; generalized anxiety disorder = 7.0% and panic disorder = 5.8%). The questionnaire demonstrated good test-retest reliability for any depressive disorder (k = .847), major depressive disorder (k = .784), generalized anxiety disorder (k = .787), panic disorder (k = .848), and for any psychiatric disorder (k = .847). There was good agreement between PHQ and SCID-I diagnoses (for any PHQ disorder. k = .821; overall accuracy = 90.43%. sensitivity = 83.84%; specificity = 97.01%). Patients with any PHQ disorder had higher impairment on the SF-36 (p<.001). HADS depression and anxiety scores showed high correlations with PHQ depression (p<.001) and anxiety (p<.001) scores respectively. PHQ administration was well accepted by 97% of patients. Conclusions: The Spanish version of the PHQ is a reliable, valid, and useful screening instrument to detect depression, generalized anxiety and panic disorders in HCV patients. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 47 条
[1]   Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students [J].
Adewuya, Abiodun O. ;
ola, B. A. Ola ;
O Afolabi, Olusegun .
JOURNAL OF AFFECTIVE DISORDERS, 2006, 96 (1-2) :89-93
[2]  
ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771
[3]   The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 [J].
Armstrong, Gregory L. ;
Wasley, Annemarie ;
Simard, Edgar P. ;
McQuillan, Geraldine M. ;
Kuhnert, Wendi L. ;
Alter, Miriam J. .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) :705-714
[4]   Health-related quality of life in patients with chronic hepatitis B [J].
Bondini, Silvia ;
Kallman, Jillian ;
Dan, Amy ;
Younoszai, Zahra ;
Ramsey, Lolita ;
Nader, Fatema ;
Younossi, Zobair M. .
LIVER INTERNATIONAL, 2007, 27 (08) :1119-1125
[5]   Hepatitis C virus: Virology, diagnosis and management of antiviral therapy [J].
Chevaliez, Stephane ;
Pawlotsky, Jean-Michel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) :2461-2466
[6]   Depression, anemia and health-related quality of life in chronic hepatitis C [J].
Dan, AA ;
Martin, LM ;
Crone, C ;
Ong, JP ;
Farmer, DW ;
Wise, T ;
Robbins, SC ;
Younossi, ZM .
JOURNAL OF HEPATOLOGY, 2006, 44 (03) :491-498
[7]   Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C [J].
Dbouk, Nader ;
Arguedas, Miguel R. ;
Sheikh, Aasim .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) :1100-1106
[8]   Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review [J].
Dieperink, E ;
Willenbring, M ;
Ho, SB .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :867-876
[9]   Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients [J].
Diez-Quevedo, C ;
Rangil, T ;
Sanchez-Planell, L ;
Kroenke, K ;
Spitzer, RL .
PSYCHOSOMATIC MEDICINE, 2001, 63 (04) :679-686
[10]   Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre [J].
Evon, D. M. ;
Verma, A. ;
Simpson, K. ;
Galanko, J. A. ;
Dougherty, K. A. ;
Fried, M. W. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) :1071-1080